232 related articles for article (PubMed ID: 29034884)
21. TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.
Comabella M; Caminero AB; Malhotra S; Agulló L; Fernández O; Reverter F; Vandenbroeck K; Rodríguez-Antigüedad A; Matesanz F; Izquierdo G; Urcelay E; López-Larios A; Sánchez A; Otero S; Tintoré M; Montalban X
Neurology; 2013 May; 80(22):2010-6. PubMed ID: 23624563
[TBL] [Abstract][Full Text] [Related]
22. Generation of human iPSC line from a patient with laterality defects and associated congenital heart anomalies carrying a DAND5 missense alteration.
Cristo F; Inácio JM; Rosas G; Carreira IM; Melo JB; de Almeida LP; Mendes P; Martins DS; Maio J; Anjos R; Belo JA
Stem Cell Res; 2017 Dec; 25():152-156. PubMed ID: 29136563
[TBL] [Abstract][Full Text] [Related]
23. Using MS induced pluripotent stem cells to investigate MS aetiology.
Fortune AJ; Fletcher JL; Blackburn NB; Young KM
Mult Scler Relat Disord; 2022 Jul; 63():103839. PubMed ID: 35523059
[TBL] [Abstract][Full Text] [Related]
24. Generation of a Sprague-Dawley-GFP rat iPS cell line.
Coppiello G; Abizanda G; Aguado N; Iglesias E; Iglesias-Garcia O; Lo Nigro A; Prosper F; Aranguren XL
Stem Cell Res; 2017 May; 21():47-50. PubMed ID: 28677538
[TBL] [Abstract][Full Text] [Related]
25. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutation.
Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Nov; 17(3):463-465. PubMed ID: 27789394
[TBL] [Abstract][Full Text] [Related]
26. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
[TBL] [Abstract][Full Text] [Related]
27. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
[TBL] [Abstract][Full Text] [Related]
28. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation.
Varga E; Nemes C; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
Stem Cell Res; 2016 Nov; 17(3):482-484. PubMed ID: 27789399
[TBL] [Abstract][Full Text] [Related]
29. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation.
Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Nov; 17(3):479-481. PubMed ID: 27789398
[TBL] [Abstract][Full Text] [Related]
30. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
31. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
[TBL] [Abstract][Full Text] [Related]
32. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
[TBL] [Abstract][Full Text] [Related]
33. Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation.
Zapata-Linares N; Rodriguez S; Salido E; Abizanda G; Iglesias E; Prosper F; Gonzalez-Aseguinolaza G; Rodriguez-Madoz JR
Stem Cell Res; 2016 Jan; 16(1):116-9. PubMed ID: 27345794
[TBL] [Abstract][Full Text] [Related]
34. Generation of three control iPS cell lines for sickle cell disease studies by reprogramming erythroblasts from individuals without hemoglobinopathies.
Paredes BD; Martins GLS; Azevedo CM; Sampaio GLA; Nonaka CKV; Silva KND; Soares MBP; Santos RRD; Souza BSF
Stem Cell Res; 2019 Jul; 38():101454. PubMed ID: 31078962
[TBL] [Abstract][Full Text] [Related]
35. Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts.
Hansen M; Varga E; Wüst T; Brouwer N; Beauchemin H; Mellink C; van der Kevie-Kersemaekers AM; Möröy T; van der Reijden B; von Lindern M; van den Akker E
Stem Cell Res; 2017 Jan; 18():26-28. PubMed ID: 28395797
[TBL] [Abstract][Full Text] [Related]
36. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
[TBL] [Abstract][Full Text] [Related]
37. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
[TBL] [Abstract][Full Text] [Related]
38. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
39. Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.
Zhang C; Cao J; Li X; Xu H; Wang W; Wang L; Zhao X; Li W; Jiao J; Hu B; Zhou Q; Zhao T
Sci China Life Sci; 2016 Sep; 59(9):950-7. PubMed ID: 27233903
[TBL] [Abstract][Full Text] [Related]
40. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
